Ultralife Corporation (ULBI) has a negative trailing P/E of -18.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 8.6 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -5.32%, forward earnings yield 11.66%.
Criteria proven by this page:
Overall SharesGrow Score: 60/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 21.5 | 0.78 | 1.11 | 0.92 | - |
| 2017 | 13.3 | 0.12 | 1.28 | 1.19 | - |
| 2018 | 4.3 | 0.02 | 1.02 | 1.23 | - |
| 2019 | 22.4 | -0.28 | 1.06 | 1.09 | - |
| 2020 | 19.7 | 0.00 | 0.88 | 0.96 | - |
| 2021 | -413.9 | 3.96 | 0.82 | 0.99 | - |
| 2022 | -523.0 | 10.61 | 0.54 | 0.47 | - |
| 2023 | 15.5 | 0.00 | 0.89 | 0.70 | - |
| 2024 | 19.5 | -1.43 | 0.92 | 0.75 | - |
| 2025 | -16.1 | 0.08 | 0.73 | 0.50 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $0.23 | $82.46M | $3.51M | 4.3% |
| 2017 | $0.48 | $85.53M | $7.65M | 8.9% |
| 2018 | $1.53 | $87.19M | $24.93M | 28.6% |
| 2019 | $0.32 | $106.8M | $5.21M | 4.9% |
| 2020 | $0.33 | $107.71M | $5.23M | 4.9% |
| 2021 | $-0.01 | $98.27M | $-230K | -0.2% |
| 2022 | $-0.01 | $131.84M | $-120K | -0.1% |
| 2023 | $0.44 | $158.64M | $7.2M | 4.5% |
| 2024 | $0.38 | $164.46M | $6.31M | 3.8% |
| 2025 | $-0.35 | $191.16M | $-5.9M | -3.1% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $0.86 | $0.86 – $0.86 | $224.9M | $224.9M – $224.9M | 1 |
